University of Padova   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Padova Italy (1222)

Organization Overview

First Clinical Trial
1992
NCT00002897
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Azienda L'ULSS 15 Alta Padovana | Azienda Ospedaliera di Padova | Azienda Ospedaliera Padova | Azienda Ospedaliera Universitaria di Padova | Az Osp Padova, Osp. Civile Padova | Biostatistic and Epidemiology Unit, Department of Enviromental Medicine and Public Health, University of Padova, Italy | Clinica Oculistica, Padova | Clinica Oculistica, Padova (Italy) | Clinica Pediatrica, Padova | Department of General Psychology, University of Padova | Department of Medicine, University of Padova. | Dept. Clinical and Experimental Medicine, University of Padova, Medical School, Padova (Italy) | Dept. of Clinical and Experimenatl Medicine, University of Padova, Italy | Dept. of Medicine, University of Padova, Medical School, Padova (Italy) | Faculty of Medicine, University of Padova (Padova, Italy) | Gian Paolo Fadini | Oncologia Ospedale di Padova | Padova University | Padova University, Department of Surgical and Gastroenterological Sciences, 1st Surgical Clinic | Padova University Hospital, Italy | UNIVERSITA DEGLI STUDI DI PADOVA (UNIPD) | Universita di Padova | University Hospital Padova | University of Padova | University of Padova, Department of Surgical and Gastroenterological Sciences, 1st Surgical Clinic | University of Padova - Italy | University of Padova, Italy | University of Padova, Medical School | University of Padova, Padova, Italy | University of Padova, School of Dental Medicine | U.O.C. Anestesia e Rianimazione. A.O. U.L.S.S.15 Alta Padovana, Presidio Camposampiero. Camposampiero - Padova | U.O.C Chirurgia Epatobiliare e dei Trapianti Epatici, AOPD

Active Ingredients

Drugs in Phase 4 Trials (20)

adalimumab (humira) (1 trial)

albumin (Human) (Plasbumin) (3 trials)

atorvastatin (lipitor) (2 trials)

cisatracurium (nimbex) (1 trial)

dapagliflozin (farxiga) (1 trial)

etanercept (enbrel) (2 trials)

fenofibrate (fenoglide) (1 trial)

furosemide (lasix) (2 trials)

infliximab (remicade) (1 trial)

insulin detemir (Levemir) (1 trial)

insulin glargine (toujeo) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

linagliptin (tradjenta) (1 trial)

N-acetyl-aspartyl-glutamate (1 trial)

plerixafor (mozobil) (2 trials)

ribavirin (virazole) (1 trial)

rocuronium (zemuron) (1 trial)

sargramostim (leukine) (1 trial)

sitagliptin (januvia) (2 trials)

spironolactone (aldactone) (1 trial)

Drugs in Phase 3 Trials (49)

anastrozole (arimidex) (1 trial)

avelumab (bavencio) (1 trial)

beclomethasone (vanceril) (1 trial)

cannabis (1 trial)

carboplatin (paraplatin) (2 trials)

cefotaxime (claforan) (1 trial)

ceftazidime (fortaz) (1 trial)

ceftriaxone (rocephin) (1 trial)

cisplatin (platinol) (2 trials)

clavulanate (Augmentin) (1 trial)

coffee (1 trial)

cyclophosphamide (cytoxan) (2 trials)

cyclosporine (sandimmune) (1 trial)

dactinomycin (cosmegen) (1 trial)

daptomycin (cubicin) (1 trial)

dextrose (2 trials)

dolutegravir (tivicay) (1 trial)

dornase alfa (pulmozyme) (1 trial)

doxorubicin (Doxil) (3 trials)

enoxaparin (lovenox) (1 trial)

etoposide (vepesid) (1 trial)

everolimus (zortress) (3 trials)

fentanyl (Innovar) (1 trial)

fluorouracil (efudex) (1 trial)

follitropin alfa (Gonal-F) (1 trial)

formoterol (foradil) (1 trial)

galactooligosaccharide (1 trial)

gentamicin (garamycin) (1 trial)

idursulfase (elaprase) (1 trial)

ifosfamide (ifex) (2 trials)

ketamine (ketalar) (2 trials)

ketotifen (zaditor) (1 trial)

lactobacillus rhamnosus (1 trial)

lamivudine (epivir) (1 trial)

letrozole (femara) (1 trial)

meropenem (merrem) (2 trials)

midodrine (proamatine) (1 trial)

nafamostat (ronastat) (1 trial)

octreotide (sandostatin) (1 trial)

procaine benzylpenicillin (novocaine) (2 trials)

propranolol (inderal) (1 trial)

rivaroxaban (xarelto) (1 trial)

ropivacaine (naropin) (2 trials)

terlipressin (Terlivaz) (2 trials)

topotecan (hycamtin) (1 trial)

urokinase (kinlytic) (1 trial)

vincristine (oncovin) (1 trial)

vinorelbine (navelbine) (1 trial)

warfarin (coumadin) (3 trials)

Drugs in Phase 2 Trials (23)

acetylcysteine (mucomyst) (1 trial)

aldesleukin (Proleukin) (1 trial)

allogeneic adipose derived mesenchymal stem cell (1 trial)

bevacizumab (avastin) (1 trial)

caspofungin (cancidas) (1 trial)

colchicine (colbenemid) (1 trial)

dexmedetomidine (precedex) (3 trials)

eltrombopag (promacta) (1 trial)

epirubicin (ellence) (1 trial)

exemestane (aromasin) (1 trial)

hepatitis b vaccine (recombinant) (Recombivax) (1 trial)

nivolumab (opdivo) (1 trial)

oxygen (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

sirolimus (rapamune) (1 trial)

sodium chloride (1 trial)

sorafenib (nexavar) (1 trial)

tacrolimus (prograf) (1 trial)

temozolomide (temodar) (1 trial)

tpi asm8 (1 trial)

triptorelin (Trelstar) (1 trial)

vatalanib (1 trial)

verteporfin (visudyne) (1 trial)

Drugs in Phase 1 Trials (3)

hivis dna vaccine (1 trial)

hpv 16/18 vaccine (Cervarix) (1 trial)

mva-cmdr (1 trial)

Drugs in Other Trials (16)

13c-leucine (1 trial)

beta-hydroxyisovaleric acid (1 trial)

butyrate (1 trial)

capecitabine (xeloda) (1 trial)

cholestyramine (questran) (1 trial)

citric acid (1 trial)

clarithromycin (biaxin) (1 trial)

cow milk (1 trial)

ibuprofen (motrin) (1 trial)

insulin degludec (tresiba) (1 trial)

lactobacillus casei (1 trial)

lutein (1 trial)

parmigiano reggiano cheese (2 trials)

sitosterol, beta- (1 trial)

sucrose (1 trial)

whey protein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acidosis (Phase 2)

Amyotrophic Lateral Sclerosis (Phase 3)

Antiphospholipid Syndrome (Phase 3)

Ascites (Phase 4)

Asthma (Phase 3)

Atrial Fibrillation (Phase 3)

Bacterial Infections (Phase 4)

Blood Platelet Disorders (Phase 2)

Breast Neoplasms (Phase 3)

Burning Mouth Syndrome (Phase 2)

Burns (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Cardiovascular Diseases (Phase 4)

Central Nervous System Neoplasms (Phase 2)

Cholangitis (Phase 4)

Communicable Diseases (Phase 3)

Conjunctivitis, Allergic (Phase 4)

Delayed Emergence from Anesthesia (Phase 4)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Retinopathy (Phase 4)

Empyema (Phase 3)

Empyema, Pleural (Phase 3)

Esophageal and Gastric Varices (Phase 3)

Esophageal Neoplasms (Phase 3)

Fibrosis (Phase 4)

Fungemia (Phase 2)

Glioblastoma (Phase 2)

Glucose Intolerance (Phase 4)

Hepatic Insufficiency (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 2)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hepatoblastoma (Phase 3)

Hepatorenal Syndrome (Phase 3)

Histiocytoma (Phase 3)

Histiocytoma, Benign Fibrous (Phase 3)

Histiocytoma, Malignant Fibrous (Phase 3)

HIV Infections (Phase 1)

Hypercholesterolemia (Phase 4)

Infections (Phase 4)

Infertility (Phase 3)

Infertility, Male (Phase 3)

Inflammation (Phase 4)

Insulin Resistance (Phase 4)

Ischemia (Phase 2)

Keratoconjunctivitis (Phase 4)

Kidney Failure, Chronic (Phase 4)

Liver Cirrhosis (Phase 4)

Liver Diseases (Phase 4)

Liver Failure (Phase 2)

Liver Failure, Acute (Phase 2)

Liver Neoplasms (Phase 3)

Macular Degeneration (Phase 2)

Mental Disorders (Phase 2)

Motor Neuron Disease (Phase 3)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Muscle Spasticity (Phase 3)

Mycoses (Phase 2)

Neoplasm Metastasis (Phase 2)

Nervous System Neoplasms (Phase 2)

Obesity, Morbid (Phase 3)

Osteoarthritis (Phase 2)

Osteoporosis (Phase 4)

Pain, Postoperative (Phase 3)

Peritonitis (Phase 3)

Pneumonia (Phase 4)

Prediabetic State (Phase 4)

Psoriasis (Phase 4)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Retinal Diseases (Phase 4)

Rhabdomyosarcoma (Phase 3)

Sarcoma (Phase 3)

Sclerosis (Phase 3)

Sepsis (Phase 3)

Status Epilepticus (Phase 3)

Substance Withdrawal Syndrome (Phase 2)

Syndrome (Phase 3)

Synovitis (Phase 2)

Thrombocytopenia (Phase 2)

Thromboembolism (Phase 3)

Thrombosis (Phase 3)

Toxemia (Phase 3)

Triple Negative Breast Neoplasms (Phase 3)

Urinary Tract Infections (Phase 4)

Venous Thromboembolism (Phase 3)

Venous Thrombosis (Phase 3)

Wet Macular Degeneration (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 86
  • # of Trial APIs: 111